PARP INHIBITORS RESTORE TEMOZOLOMIDE SENSITIVITY IN MSH6-DEFICIENT TEMOZOLOMIDE-RESISTANT GLIOMA MODELS

Higuchi, F; Wakimoto, H; Cahill, D

NEURO-ONCOLOGY, 2017; 19 ( ): 67